Jerusalem, April 14 (IANS) US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation
Research Shows New Bivalent Covid-19 Booster Vaccine Highly Effective in Reducing Deaths and Hospitalizations miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Hospitalisation due to COVID-19 occurred in 32 participants who received a bivalent mRNA booster vaccination and 541 who did not receive a bivalent booster vaccination. Analysis showed this to mean a 72 per cent reduction in hospitalisation risk in those receiving the bivalent booster. Pfizer Bivalent Vaccine Reduces COVID-19-Related Death Risk by 68% in Older People: Study.